Experts emphasized the importance of addressing regulatory and payer-side challenges to fully leverage AI's potential in pharmacy settings.
Harry Travis
Advertisement
Articles by Harry Travis
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Interchangeability Designation to Denosumab Biosimilars Stoboclo and Osenvelt
2
Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation
3
Improving RSV Vaccine Coverage Could Prevent Thousands of Severe Cases in Older Adults
4
PCV20 Demonstrates Real-World Effectiveness Against Pneumonia in Older Adults
5
